Sotabase

Career

· Broker, Tradelink Securities, LLC2017–2024
· Broker, Tradelink L.L.C.2005–2013
· Broker, Rodman & Renshaw Inc.1992–1994
· President, Tradelink Capital LLC
· President, Tradelink Holdings LLC
· President/COO, Tradelink LLC
· Bachelor's degree, University of Illinois Chicago
· MBA, University of Illinois Chicago

Publications (271)

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
The Lancet · 2018
601
cited
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer Network · 2020
521
cited
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
The Lancet Oncology · 2020
334
cited
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
European Urology · 2015
283
cited
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer Network · 2017
247
cited
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
The Journal of the National Comprehensive Cancer Network · 2022
231
cited
Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology.
Journal of Urology · 2012
212
cited
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
The Journal of the National Comprehensive Cancer Network · 2018
212
cited
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
Urologic oncology · 2013
168
cited
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions
Medical decision making · 2017
120
cited
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy.
Cancer Research · 2015
113
cited
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
Journal of Urology · 2016
107
cited
Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
Journal of Clinical Oncology · 2002
107
cited
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance
Open Access Journal of Urology · 2011
104
cited
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
European Urology · 2017
104
cited
The androgen receptor gene and its influence on the development and progression of prostate cancer
Journal of Pathology · 2001
96
cited
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer
Cancer · 2014
76
cited
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update
BJU International · 2015
75
cited
A matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy.
Journal of Urology · 2012
74
cited
Disparities in bladder cancer.
Urologic oncology · 2012
73
cited
Sotabase
Claire Montgomery | Researcher Profile | Sotabase | Sotabase